Published in J Virol on February 01, 2001
Recombination in eukaryotic single stranded DNA viruses. Viruses (2011) 1.20
Within-host genetic diversity of endemic and emerging parvoviruses of dogs and cats. J Virol (2008) 0.99
Rolling hairpin model for replication of parvovirus and linear chromosomal DNA. Nature (1976) 3.61
Construction of an infectious molecular clone of the autonomous parvovirus minute virus of mice. J Virol (1983) 2.95
Replication fork arrest and DNA recombination. Trends Biochem Sci (2000) 2.91
DNA sequence of the lymphotropic variant of minute virus of mice, MVM(i), and comparison with the DNA sequence of the fibrotropic prototype strain. J Virol (1986) 2.89
Programmed killing of human cells by means of an inducible clone of parvoviral genes encoding non-structural proteins. EMBO J (1990) 2.35
Lymphokine gene therapy for cancer. Immunol Today (1990) 2.30
DNA sequence comparison between two tissue-specific variants of the autonomous parvovirus, minute virus of mice. Nucleic Acids Res (1985) 2.24
DNA sequence of the 5' terminus containing the replication origin of parvovirus replicative form DNA. J Virol (1982) 2.01
Incomplete genomes of the parvovirus minute virus of mice: selective conservation of genome termini, including the origin for DNA replication. J Virol (1979) 1.82
Minute virus of mice non-structural protein NS-1 is necessary and sufficient for trans-activation of the viral P39 promoter. J Gen Virol (1988) 1.81
An asymmetric nucleotide in the parvoviral 3' hairpin directs segregation of a single active origin of DNA replication. EMBO J (1994) 1.79
NS-1 and NS-2 proteins may act synergistically in the cytopathogenicity of parvovirus MVMp. Virology (1990) 1.72
Dicistronic transcription units for gene expression in mammalian cells. Gene (1993) 1.66
Terminal regions of the NS-1 protein of the parvovirus minute virus of mice are involved in cytotoxicity and promoter trans inhibition. J Virol (1992) 1.64
Defective interfering particles of parvovirus H-1. J Virol (1978) 1.44
cis requirements for the efficient production of recombinant DNA vectors based on autonomous parvoviruses. Hum Gene Ther (1999) 1.39
Deletions at stalled replication forks occur by two different pathways. EMBO J (1997) 1.37
Short-homology-independent illegitimate recombination in Escherichia coli: distinct mechanism from short-homology-dependent illegitimate recombination. J Mol Biol (1997) 1.32
Mechanisms of illegitimate recombination. Gene (1993) 1.27
Replication of minute virus of mice minigenomes: novel replication elements required for MVM DNA replication. Virology (1993) 1.17
Isolation of a fully infectious variant of parvovirus H-1 supplanting the standard strain in human cells. J Virol (1995) 1.15
Molecular characterization of a newly recognized mouse parvovirus. J Virol (1994) 1.08
Multiple cellular factors bind to cis-regulatory elements found inboard of the 5' palindrome of minute virus of mice. J Virol (1994) 1.00
Molecular characterization of newly recognized rodent parvoviruses. J Gen Virol (1996) 0.97
Transformation-dependent expression of interleukin genes delivered by a recombinant parvovirus. J Virol (1992) 0.96
Minute virus of mice cis-acting sequences required for genome replication and the role of the trans-acting viral protein, NS-1. Prog Nucleic Acid Res Mol Biol (1996) 0.93
Non-homologous recombination mediated by Thermus aquaticus DNA polymerase I. Evidence supporting a copy choice mechanism. Nucleic Acids Res (1998) 0.93
ras oncogene-dependent activation of the P4 promoter of minute virus of mice through a proximal P4 element interacting with the Ets family of transcription factors. J Virol (1996) 0.91
Two spatially distinct genetic elements constitute a bipartite DNA replication origin in the minute virus of mice genome. J Virol (1991) 0.91
Nonhomologous recombination in the parvovirus chromosome: role for a CTATTTCT motif. Mol Cell Biol (1986) 0.89
Analysis of the internal replication sequence indicates that there are three elements required for efficient replication of minute virus of mice minigenomes. J Virol (1997) 0.88
The effect of regulatory sequence elements upon the initiation of DNA replication of the minute virus of mice. Virology (1996) 0.87
Cloning and characterization of DNAs with palindromic sequences. Genet Eng (N Y) (1996) 0.84
Molecular characterization of tomato spotted Wilt virus defective interfering RNAs and detection of truncated L proteins. Virology (1998) 0.83
Autonomous parvovirus and densovirus gene vectors. Adv Virus Res (1996) 0.83
Characterization of Toscana virus-defective interfering particles generated in vivo. Virology (1998) 0.82
Influence of sequence and size of DNA on packaging efficiency of parvovirus MVM-based vectors. Hum Gene Ther (1999) 0.82
A novel packaging system for the generation of helper-free oncolytic MVM vector stocks. Gene Ther (1996) 0.78
Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med (1993) 4.30
Brief report: clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome. N Engl J Med (1994) 2.96
Programmed killing of human cells by means of an inducible clone of parvoviral genes encoding non-structural proteins. EMBO J (1990) 2.35
Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur J Immunol (1994) 2.04
Recombinant AAV-mediated gene delivery to the central nervous system. J Gene Med (2004) 1.94
Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia. Eur J Immunol (1994) 1.92
Interleukin-10 modulates susceptibility in experimental cerebral malaria. Immunology (1997) 1.73
NS-1 and NS-2 proteins may act synergistically in the cytopathogenicity of parvovirus MVMp. Virology (1990) 1.72
Preferential activation of Th2 cells in chronic graft-versus-host reaction. J Immunol (1993) 1.50
TH2 activated cells prevent experimental autoimmune uveoretinitis, a TH1-dependent autoimmune disease. Eur J Immunol (1993) 1.44
Interleukin-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells. Eur J Immunol (1995) 1.43
[New therapeutic approachs in melanoma]. Rev Med Brux (2004) 1.40
Interleukin 10 prevents necrosis in murine experimental acute pancreatitis. Gastroenterology (1995) 1.37
B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10. J Immunol (1994) 1.33
Radiation-induced base substitution mutagenesis in single-stranded DNA phage M13. Nature (1981) 1.18
Indirect SOS induction is promoted by ultraviolet light-damaged miniF and requires the miniF lynA locus. J Mol Biol (1984) 1.11
In vivo induction of interleukin 10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: differential modulation by cyclosporin A. J Exp Med (1993) 1.10
Absence of Epstein-Barr virus in medullary carcinoma of the breast as demonstrated by immunophenotyping, in situ hybridization and polymerase chain reaction. Am J Clin Pathol (1995) 1.09
Tetracycline-inducible transgene expression mediated by a single AAV vector. Gene Ther (2003) 1.08
Gratuitous induction. J Mol Biol (1984) 1.05
Effects of substitution of threonine 654 of the epidermal growth factor receptor on epidermal growth factor-mediated activation of phospholipase C. J Biol Chem (1990) 1.01
T helper type 2-like cells and therapeutic effects of interferon-gamma in combined immunodeficiency with hypereosinophilia (Omenn's syndrome). Eur J Immunol (1993) 1.00
Cyclosporin-associated fatal convulsions. Lancet (1985) 0.99
XSIP1, a Xenopus zinc finger/homeodomain encoding gene highly expressed during early neural development. Mech Dev (2000) 0.97
Transformation-dependent expression of interleukin genes delivered by a recombinant parvovirus. J Virol (1992) 0.96
The biological activity of the human epidermal growth factor receptor is positively regulated by its C-terminal tyrosines. Oncogene (1991) 0.92
Controlled delivery of glial cell line-derived neurotrophic factor by a single tetracycline-inducible AAV vector. Exp Neurol (2007) 0.90
Interleukin-10 inhibits the induction of monocyte procoagulant activity by bacterial lipopolysaccharide. Eur J Immunol (1993) 0.89
Relative contribution of Ki-ras gene analysis and brush cytology during ERCP for the diagnosis of biliary and pancreatic diseases. Gastrointest Endosc (1998) 0.89
Loss of tumorigenicity and increased immunogenicity induced by interleukin-10 gene transfer in B16 melanoma cells. Hum Gene Ther (1996) 0.88
Spontaneous and cycloheximide-induced interleukin-10 mRNA expression in human mononuclear cells. Mol Immunol (1995) 0.87
Nanomolar range docetaxel treatment sensitizes MCF-7 cells to chemotherapy induced apoptosis, induces G2M arrest and phosphorylates bcl-2. Anticancer Res (1999) 0.86
The genome structure of a new chicken virus identifies it as a parvovirus. J Gen Virol (1985) 0.86
Neonatal induction of transplantation tolerance in mice is associated with in vivo expression of IL-4 and -10 mRNAs. Transplant Proc (1993) 0.86
Transient expansion of peptide-specific lymphocytes producing IFN-gamma after vaccination with dendritic cells pulsed with MAGE peptides in patients with mage-A1/A3-positive tumors. J Leukoc Biol (2001) 0.85
Intrathyroidal cytokine gene expression profiles in autoimmune thyroiditis. J Endocrinol (1994) 0.84
Tropism of AAV-2 vectors for neurons of the globus pallidus. Neuroreport (2000) 0.84
Transfer of p16inka/CDKN2 gene in leukaemic cell lines inhibits cell proliferation. Br J Haematol (1996) 0.83
Interleukin-10: actions and therapeutic potential. BioDrugs (1997) 0.83
Interleukin 10 inhibits inflammatory cells infiltration in endotoxin-induced uveitis. Graefes Arch Clin Exp Ophthalmol (1996) 0.83
Requirement of protein and RNA synthesis for lambda repressor inactivation by tif-1: effects of chloramphenicol, neomycin and rifampicin. Mol Gen Genet (1978) 0.83
Influence of sequence and size of DNA on packaging efficiency of parvovirus MVM-based vectors. Hum Gene Ther (1999) 0.82
The protective role of interleukin-10 in endotoxin shock. Prog Clin Biol Res (1994) 0.82
Tumor-selective gene transduction and cell killing with an oncotropic autonomous parvovirus-based vector. Gene Ther (2000) 0.82
Role and expression of CD40 on human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci (2000) 0.82
A novel MVMp-based vector system specifically designed to reduce the risk of replication-competent virus generation by homologous recombination. Gene Ther (2001) 0.81
Cellular contaminants of adeno-associated virus vector stocks can enhance transduction. Gene Ther (1999) 0.81
Cancer escape from immune surveillance: how can it be overcome by gene transfer? Eur J Cancer (1994) 0.80
Interleukin-10 and its implications for immunopathology. Adv Nephrol Necker Hosp (1995) 0.80
The role of cellular- and prodrug-associated factors in the bystander effect induced by the Varicella zoster and Herpes simplex viral thymidine kinases in suicide gene therapy. Cancer Gene Ther (2000) 0.80
Varying sensitivity of human mammary carcinoma cells to the toxic effect of parvovirus H-1. Eur J Cancer (1997) 0.80
AAV2 vectors mediate efficient and sustained transduction of rat embryonic ventral mesencephalon. Neuroreport (2002) 0.80
Positive selection of human cells lacking several transformation parameters from an SV40-transformed culture by means of parvovirus H-1. Carcinogenesis (1988) 0.79
Signal transduction in hamster fibroblasts overexpressing the human EGF receptor. Growth Factors (1989) 0.79
Retinal pigment epithelial cells phagocytosis of T lymphocytes: possible implication in the immune privilege of the eye. Br J Ophthalmol (2002) 0.79
Efficient early and sustained transduction of human fetal mesencephalon using adeno-associated virus type 2 vectors. Cell Transplant (2004) 0.78
Modulation of the release of cytokines and reduction of the shock syndrome induced by anti-CD3 monoclonal antibody in mice by interleukin-10. Transplantation (1994) 0.78
High level expression of p55, a thyroid hormone binding protein which is homologous to protein disulfide isomerase in a retroviral vector. Biochem Biophys Res Commun (1989) 0.78
Mutagenesis at putative apurinic sites in alkylated single-stranded DNA of parvovirus H-1 propagated in human cells. Mutat Res (1985) 0.78
Inhibition and recovery of the replication of depurinated parvovirus DNA in mouse fibroblasts. Adv Exp Med Biol (1984) 0.78
Cyclosporine in refractory severe aplastic anemia. N Engl J Med (1984) 0.78
[Chorioretinal lymphoproliferative disorder induced by Epstein-Barr virus in lung transplantation]. Bull Soc Belge Ophtalmol (1995) 0.78
Involvement of the p53 tumor suppressor gene in Ph1-positive and Ph1-negative myeloid leukemia. Blood (1990) 0.77
Over-expression of the epidermal growth factor receptor in human breast cancer cells fails to induce an estrogen-independent phenotype. Int J Cancer (1990) 0.77
Disseminated angiosarcoma presenting as a hemophagocytic syndrome in a renal allograft recipient. Transpl Int (1997) 0.77
Micronuclei to detect in vivo chemotherapy damage in a p53 mutated solid tumour. Br J Cancer (2003) 0.77
Generation of immature autologous clinical grade dendritic cells for vaccination of cancer patients. Cytotherapy (1999) 0.77
Curative potential of herpes simplex virus thymidine kinase gene transfer in rats with 9L gliosarcoma. Hum Gene Ther (1996) 0.77
Neuroprotective gene therapy for Parkinson's disease. Curr Gene Ther (2002) 0.77
Gene therapy for glioblastoma [correction of gliobestome] multiform: in vivo tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. J Mol Med (Berl) (1997) 0.76
Interleukin-10 inhibits OKT3-induced cytokine release: in vitro comparison with pentoxifylline. Transplant Proc (1993) 0.76
IL-10 inhibits the primary allogeneic T cell response to human peripheral blood dendritic cells. Adv Exp Med Biol (1995) 0.76
Therapeutic effect of human recombinant interferon-alpha-2C in essential thrombocythaemia. Oncology (1985) 0.75
Chorioretinal post-transplant lymphoproliferative disorder induced by the Epstein-Barr virus. Br J Ophthalmol (2001) 0.75
CXCR4 expression in vitreoretinal membranes. Br J Ophthalmol (2003) 0.75
Skin biopsies in DC vaccines for stage III-IV melanoma patients: role of neutrophils? Arch Dermatol Res (2007) 0.75
IL-5 in post-traumatic eosinophilic pleural effusion. Clin Exp Immunol (1993) 0.75
TH1-type immune response in lymphocyte-predominance Hodgkin's disease. Br J Haematol (1995) 0.75
Helper T cell dysfunctions in a patient with Omenn's syndrome: modulation by IFN-gamma therapy. Immunodeficiency (1993) 0.75
[Topical photodynamic therapy in cutaneous oncology]. Rev Med Brux (2004) 0.75
Nature of the T lymphocytes in lymphocyte predominance Hodgkin's disease. Leuk Lymphoma (1997) 0.75
A case of pleomorphic T-cell lymphoma with a high content of reactive histiocytes presented with hypereosinophilia. Pathol Res Pract (1995) 0.75
[Do androgens have a therapeutic role in hematology?]. Rev Med Brux (1985) 0.75
Gene therapy: socioeconomic and ethical issues. A roundtable discussion. Hum Gene Ther (1996) 0.75
[Blastic lymphoid cells in the bone marrow of an infant]. Ann Pathol (1997) 0.75
Contribution of molecular oncology in the detection of colorectal carcinomas. Acta Gastroenterol Belg (1996) 0.75
European School of Oncology position paper. Gene therapy for the medical oncologist. Eur J Cancer (1995) 0.75
[Anti-tumor immunotherapy based on dendritic cells]. J Soc Biol (2001) 0.75
[Virus and cancer. Role of sexually transmissible viruses in carcinogenesis]. Acta Urol Belg (1993) 0.75
Infectious mononucleosis complicated by transverse myelitis: detection of the viral genome by polymerase chain reaction in the cerebrospinal fluid. J Neurol (1997) 0.75
Morphologic and phenotypic changes of the leukemic cells in a case of marginal zone B-cell lymphoma. Ann Hematol (1997) 0.75
Effects of interleukin-10 on the immunoactivating and immunosuppressive properties of anti-CD3 monoclonal antibody. Transplant Proc (1994) 0.75
Treatment of essential thrombocythaemia by alpha-interferon. Lancet (1988) 0.75
Lack of intrathyroidal tumor necrosis factor alpha in Graves' disease. J Clin Endocrinol Metab (1993) 0.75
Role of the TH1-TH2 balance in the development of autoimmunity in rats. Transplant Proc (1993) 0.75
Overexpression of mouse IsK protein fused to green fluorescent protein induces apoptosis of human astroglioma cells. Neurol Res (2007) 0.75
Vectors in cancer therapy: how will they deliver? Cancer Gene Ther (1995) 0.75